Cannabis Science Inc. Cannabis Science Inc.
Cannabis Science Inc. Cannabis Science Inc.
  • Home
  • About Us
    • Corporate Overview
    • Mission Statement
    • Cannabis Science Team
    • Careers & Corporate Culture
  • iCannabinoid
    • Join Now!
  • R&D
    • The Science of Cannabinoids
    • CBIS Cannabinoid Research
    • Critical Ailments
  • COLLABORATIONS & PROJECTS
    • CBIS Medical Consortium
    • Global Economic Development
    • Pan African A & C University
    •     African Economic Initiative
    • American States University
    •     North American Economic Initiative
    • Dana-Farber
    • CFA
    • Stellenbosch University
    • CBIS Bottle It
  • Products & Pharmacies
    • Products
    • Order Online
    • Pharmacies
  • Investors
    • CBIS Current Share Structure
    • SEC Filings
  • Media
    • CBIS News Releases
    • CBIS In The News
    • CBIS Events
  • Contact

latest Articles

  • Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
  • Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
  • Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
  • Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
  • Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations

  1. Home

Total: 448 results found.

Page 10 of 23

Prop 64 Voting Fuels Cannabis Science to Expand Land Deals Across the Country and Increase Drug Development Programs, Laboratory Extractions, and New Product Releases

Created on 2018-06-12 17:26:10

Montana Pain Management in Breach of Non-Disclosure/Non-Circumvention Agreement with Cannabis Science

Created on 2018-06-12 17:14:59

Cannabis Science Signs First Licensing Agreement With RockBrook for Manufacturing, Development, and Distribution of the Cannabis Science Brand of Pharmaceutical Products for the State of Colorado as State Legislation Forces Cancellation of RockBrook Acqui

Created on 2018-06-12 17:13:33

Cannabis Science Signs Joint Venture With Smokefree Innotec Inc. to Develop High-Tech Smoke-Free Vaporized Medical Cannabis Products

Created on 2018-06-12 17:12:22

Cannabis Science has Taken a Leadership Role to Progress its Pharmaceutical Products Under the New Policies the Federal Government has Implemented for the Use of Medical Cannabis

Created on 2018-06-12 17:10:52

Cannabis Science Comments on NY Times Article Regarding Major Support From Veterans Affairs for Medical Marijuana; Cannabis Science Hails the New Veterans Affairs Policies on Medical Marijuana for Disabled Vets as Validation of Company's FDA Focus on Help

Created on 2018-06-12 17:09:57

Cannabis Science Acquires New 9,500 Square Foot Denver Facility for Researching, Developing, Testing, and Producing Medical Cannabis for Patients

Created on 2018-06-12 17:08:31

Prominent Psychiatrist, Addiction Expert, Joins Cannabis Science Advisory Board; Dr. Arturo Morales Says, "Prohibition Imposed on Medical Cannabis Has No Scientific Foundation"

Created on 2018-06-12 17:07:34

Cannabis Science Hails Latest International Recognition of Medical Cannabis By Big Pharma

Created on 2018-06-12 17:06:35

Cannabis Science CEO, Dr. Robert Melamede PhD, to Speak at "First-Ever Live and On Demand Continuing Education in Medical Marijuana Science, Law and Horticulture" With 420 University

Created on 2018-06-12 17:05:31

Cannabis Science Begins Expansion of Production and Research at Montana Pain Management

Created on 2018-06-12 17:04:42

Cannabis Science Reports Important Validation for Medical Cannabis as Bayer Pays '$15 Million Milestone Payment' for GW Pharmaceuticals' Sativex(R) for MS, as the UK Government Approves "First Prescription Cannabis Medicine"

Created on 2018-06-12 16:44:41

Governor Schweitzer's Visit to Cannabis Science Acquisition, Montana Pain Management, Draws Extensive Media Coverage; Governor "Impressed by the Sophistication" of Operation Model for New State Regulations

Created on 2018-06-12 16:43:43

Montana Governor Brian Schweitzer Visits New Cannabis Science Acquisition

Created on 2018-06-12 16:42:46

Cannabis Science Jumps With Its Next Acquisition; Montana Pain Management, Inc., One of the Leading Medical Marijuana Providers in the State of Montana

Created on 2018-06-12 16:41:53

CBIS Announces Federal Court Order for CBIS Shares Owned by Cannex Therapeutics Controlled by Steve Kubby to be Cancelled and Re-Issued to K&D Equity Investments Inc.

Created on 2018-06-12 16:41:03

Cannabis Science Anticipates Marijuana Legalization as Latest Polls Show Legalization Leading 49% in Favor With 41% Opposed; Los Angeles City Efforts to Close Medical Dispensaries Will Help Drive to End Prohibition

Created on 2018-06-12 16:40:03

Cannabis Science President and CEO Dr. Robert Melamede, PhD., Files Preliminary Patent Disclosures With the University of Colorado Regarding New Technology That Cannabis Science Intends to Develop Through a Private Company Acquisition

Created on 2018-06-12 16:37:23

Cannabis Reports on Bloomberg News, 15 Members of Congress Led by Representative Barney Frank Support Dispensaries as Legitimate Businesses; Cannabis Science Value Increased for Pharmaceutical Research and Development; New Colorado Law Adds Protection

Created on 2018-06-12 16:36:26

Cannabis Science Acquires Two Revenue Producing Operations, a Medical Marijuana Growing Facility and a Dispensary to Facilitate Operational Growth, Research and Development of Pharmaceutical Cannabis Products in Colorado in Accordance With State Laws

Created on 2018-06-12 16:35:23

  • Start
  • Prev
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • Next
  • End
REACH US.

2019 US Federal Contractor

DUNS number: 830406356
CAGE code: 5FZM9

NAICS Codes selected:

541711 - Research and Development in Biotechnology

621511 - Medical Laboratories

624230 - Emergency And Other Relief Services

Contact.

Cannabis Science Inc.

Mr. Raymond C. Dabney
President & CEO

raymond.dabney@cannabisscience.com



 
 
Copyright © 2019 Cannabis Science Inc. All Rights Reserved.